Perrigo Agrees to $10 Million Formula Settlement
Perrigo has agreed to pay $10 million to settle a proposed class-action lawsuit alleging that it conspired with Gerber Products to restrict competition in the United States store-brand infant formula market. The lawsuit claims that the alleged arrangement prevented new competitors from entering the market and allowed prices for store-brand baby formula to rise. The proposed settlement was submitted to a federal court in Brooklyn, New York, and requires judicial approval before it becomes final. The agreement represents a significant development in a legal dispute involving competition, consumer protection, and the cost of essential infant nutrition products.
The lawsuit centers on allegations that Perrigo and Gerber worked together in ways that limited opportunities for other businesses to compete in the store-brand infant formula market. Store-brand formula is manufactured for retailers and sold under their own labels, often at prices lower than comparable nationally recognized brands. Consumers may choose these products as a more affordable option when purchasing essential nutrition for infants. The plaintiffs allege that the arrangement between the companies restricted market entry and reduced competitive pressure, allowing Perrigo to charge higher prices that retailers ultimately passed on to customers.
Perrigo is a major supplier of store-brand infant formula in the United States. Its products serve retailers that sell formula under their own names rather than under the manufacturer’s brand. Because these products compete largely on price, the availability of multiple suppliers can be important to maintaining competition. The plaintiffs argue that restricting the entry of additional manufacturers weakened that competition and harmed consumers financially. However, these claims remain allegations, and Perrigo has denied wrongdoing. The proposed settlement does not itself establish that the company violated antitrust laws.
The proposed class action covers customers who purchased store-brand infant formula manufactured or sold by Perrigo beginning in April 2020. Attorneys representing the plaintiffs estimate that millions of consumers across the United States could fall within the proposed class. The potential size of the group reflects the widespread use of store-brand formula by families seeking affordable infant nutrition. If the court approves the settlement, eligible consumers may be able to benefit from the agreement under the terms ultimately established for the class. The available report does not specify individual payment amounts or provide a complete claims process.
The $10 million settlement is intended to resolve the claims against Perrigo in this consumer lawsuit. Rather than continuing to litigate those claims through a potentially lengthy trial, the company has agreed to provide financial compensation under the proposed agreement. Settlements can reduce the time and expense associated with litigation, but they do not necessarily represent an admission of liability. Perrigo has denied wrongdoing, and the proposed settlement remains subject to the judge’s approval. The court must consider the agreement before it can become an effective resolution of the claims covered by the deal.
The agreement also includes a commitment by Perrigo to refrain for three years from entering into agreements with infant formula businesses that restrict competition for store-brand formula without a legitimate business reason. This provision is an important part of the proposed resolution because it addresses future commercial arrangements, not only the financial claims arising from past conduct. Restrictions on agreements that limit competition may help preserve opportunities for competing suppliers, although the practical effect will depend on how the provision is interpreted and implemented. The agreement does not mean that every business arrangement between formula manufacturers will be prohibited.
Another important feature of the settlement is Perrigo’s agreement to cooperate with the plaintiffs in their ongoing lawsuit against Gerber. The company has agreed to make directors, officers, and employees available to testify and to provide transaction data. These commitments could help the plaintiffs develop evidence concerning the companies’ commercial dealings and the alleged effects on market competition. Such evidence may be relevant to determining whether the challenged arrangements restricted competition and whether consumers suffered financial harm. Gerber has also denied wrongdoing, and the claims against it remain subject to the ongoing legal process.
The continuing case illustrates the distinction between resolving a lawsuit against one defendant and determining the liability of another. Perrigo’s proposed settlement addresses the claims against Perrigo under the agreement’s terms, while the litigation involving Gerber continues. Cooperation and access to company records may provide the plaintiffs with additional information about the alleged conduct. Nevertheless, the existence of a settlement does not automatically prove the allegations against Gerber or predetermine the outcome of the remaining proceedings. Any findings of liability must be established through the applicable legal process.
The dispute also raises broader questions about competition in markets for essential consumer products. Infant formula is an important source of nutrition for many families, and price differences can affect household budgets. When consumers have fewer suppliers to choose from, they may have less ability to find affordable alternatives. Antitrust laws are designed to address certain forms of conduct that unlawfully restrict competition, protect market access, or harm consumers. The allegations in this case highlight why commercial agreements between major suppliers can receive scrutiny when they may affect the availability and pricing of essential goods.
For families who purchase store-brand infant formula, the settlement may be relevant because it addresses allegations that competition was restricted and prices were inflated. However, consumers should not assume that every purchaser will receive a payment or that individual compensation has already been determined. Eligibility, payment amounts, and claim procedures depend on the final settlement terms and the court’s approval. The reported agreement establishes a proposed $10 million settlement fund, but additional details would be needed to explain how any money would be distributed to eligible class members.
Ultimately, Perrigo’s proposed settlement marks an important development in the legal challenge over store-brand infant formula pricing. The company has agreed to pay $10 million, accept a three-year restriction on certain competition-limiting agreements, and cooperate in the continuing case against Gerber. At the same time, Perrigo denies wrongdoing, Gerber has denied wrongdoing, and the proposed agreement still requires judicial approval. The case highlights the importance of competition in consumer markets and the potential consequences of commercial arrangements alleged to limit market entry. The final legal implications will depend on the court’s review of the settlement and the outcome of the remaining litigation.
Key Legal Outcomes
- Proposed $10 million settlement: Perrigo has agreed to pay $10 million to resolve a proposed consumer class action over store-brand infant formula prices.
- Court approval required: The settlement must receive approval from a federal judge before it becomes final.
- Three-year competition restriction: Perrigo has agreed to avoid certain agreements that restrict competition in store-brand infant formula without a legitimate business reason.
- Cooperation with plaintiffs: Perrigo will provide transaction data and make directors, officers, and employees available to testify in the ongoing case against Gerber.
- Remaining claims continue: Gerber denies wrongdoing, and the lawsuit against it remains ongoing.
Why It Matters
- Consumer affordability: The case concerns allegations that restricted competition contributed to higher prices for an essential product used by families.
- Market competition: The settlement highlights the importance of allowing competing manufacturers to enter and participate in the infant formula market.
- Corporate accountability: The agreement demonstrates how companies may face financial and contractual consequences when their business practices are challenged under antitrust laws.
- Future business agreements: The three-year restriction could influence how Perrigo structures certain commercial arrangements with other formula businesses.
- Potential consumer relief: Millions of consumers may fall within the proposed class, although individual eligibility and payments depend on the final approved settlement terms.
Editorial note: The settlement resolves proposed claims against Perrigo only if approved by the court. The allegations have not been established as proven wrongdoing, and the case against Gerber continues.
